| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Small Business > When a Small Business Dies, We All Croak |
|
Advice You - When a Small Business Dies, We All Croak
I like frogs. At night I sit on my deck and listen to them harmonize with the crickets. Their serenade makes me feel less suburban and more like I’m living on Golden Pond. Then the hum According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product of distant traffic washes over my little Wind In The Willows and I begin to worry. Frog populations in the U.S. have showed increasing signs of stress in recent years. Some species hav ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in e disappeared and others are no longer found where they used to be. An increase in deformities may also be a sign that something is wrong. Scientists are concerned because the health of lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. frogs is closely linked to the health of the environment. Lest you think this is a pitch for Frogwatch USA™, consider this: frogs and small businesses are both indicator species, creat here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ures with such a narrow range of ecological tolerance that their presence or absence is a good indication of environmental conditions. According to the U.S. Small Business Administrati d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro on, there were 671,800 new businesses formed in 2006 and 544,800 business closures (findings do not differ greatly across industry sectors). That reveals a net gain, but the effects of ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc he estimated 25.8 million small businesses in the United States on the economy underscore the importance of survival in greater numbers. Small businesses: • Employ 50 percent of the c easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ountry’s private sector workforce. • Generated 60 to 80 percent of net new jobs annually over the last decade. • Represent 97 percent of all the exporters of goods. • Represent 99.7 nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically percent of all employer firms. • Generate a majority of the innovations that come from U.S. companies. Despite optimism by owners, many small businesses have showed signs of stress in and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ recent years. Many have disappeared, are no longer where they used to be, or have changed so much that they no longer have a competitive edge. Of course, there are many good reasons why ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi businesses fail. In this world, change is constant and flexibility is a requirement. But a frog with three legs will never win a hopping contest. A comprehensive yet flexible marketin ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a g plan will help you make logical decisions about your business, even as conditions around you change. Frogs are naturals at this kind of thing and we could learn a thing or two from ho dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod they go about their business: • Shed your skin as you grow, but not before you’re ready; overextending yourself can lead to your demise. • Change the color of your skin (i.e., the fo cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin cus of your service or product offerings) in keeping with your surroundings, but don’t do so without understanding your target markets. • Maximize your resources; some frogs can pull t tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen heir eyes back into their head in order to aid swallowing. When big opportunities come your way, take advantage of the talent and manpower you already have. • Learn to wait out the bad t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel times whenever possible. Some frogs can survive in conditions well below freezing, then lay as many as 25,000 eggs when things heat up again. • Use a variety of methods to attract new ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust customers. Frogs may sing, change color, or even dance in their efforts to attract a mate. • Watch out for the competition; learn who they are and as much about how they do business as y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products possible, then respond appropriately. The African clawed frog can excrete a compound through its skin that causes uncontrollable yawning and gaping in snakes that try to eat them. Abo . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e all else, remember that business people—like frogs—are tough. The golden poison arrow frog of Columbia has a skin secretion that is so deadly it cannot be handled by bare hands. Nativ elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e Americans used the poison to coat their hunting arrows. Just 0.2 micrograms of this poison in your bloodstream would kill you—or your competition. Your business would probably survive tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Advertising-The Best Marketing Tip The Eight Best Franchise Opportunities Of 2006
|